​

Ardelyx (ARDX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Ardelyx Revenue Highlights

Latest Revenue (Y)

$333.62M

Latest Revenue (Q)

$110.33M

Main Segment (Y)

Product

Main Geography (Y)

UNITED STATES

Ardelyx Revenue by Period

Ardelyx Revenue by Year

DateRevenueChange
2024-12-31$333.62M168.06%
2023-12-31$124.46M138.61%
2022-12-31$52.16M416.57%
2021-12-31$10.10M33.36%
2020-12-31$7.57M43.36%
2019-12-31$5.28M102.57%
2018-12-31$2.61M-93.79%
2017-12-31$42.00M74.81%
2016-12-31$24.03M-
2015-12-31$24.03M-24.02%
2014-12-31$31.62M9.32%
2013-12-31$28.93M434.71%
2012-12-31$5.41M-

Ardelyx generated $333.62M in revenue during NA 2024, up 168.06% compared to the previous quarter, and up 6317.27% compared to the same period a year ago.

Ardelyx Revenue by Quarter

DateRevenueChange
2025-09-30$110.33M12.97%
2025-06-30$97.66M31.77%
2025-03-31$74.11M-36.18%
2024-12-31$116.13M18.21%
2024-09-30$98.24M34.17%
2024-06-30$73.22M59.10%
2024-03-31$46.02M33.93%
2023-12-31$34.36M-39.06%
2023-09-30$56.39M152.50%
2023-06-30$22.33M96.44%
2023-03-31$11.37M-74.27%
2022-12-31$44.18M786.04%
2022-09-30$4.99M97.39%
2022-06-30$2.53M439.74%
2022-03-31$468.00K-54.52%
2021-12-31$1.03M-12.28%
2021-09-30$1.17M-10.66%
2021-06-30$1.31M-80.05%
2021-03-31$6.58M263.85%
2020-12-31$1.81M-33.32%
2020-09-30$2.71M47.77%
2020-06-30$1.84M51.36%
2020-03-31$1.21M-46.09%
2019-12-31$2.25M-25.32%
2019-09-30$3.01M16638.89%
2019-06-30$18.00K100.00%
2019-03-31--100.00%
2018-12-31$85.00K-50.58%
2018-09-30$172.00K473.33%
2018-06-30$30.00K-98.71%
2018-03-31$2.32M-94.48%
2017-12-31$42.00M100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30--100.00%
2015-06-30$18.14M208.40%
2015-03-31$5.88M-7.19%
2014-12-31$6.34M-16.57%
2014-09-30$7.60M-16.84%
2014-06-30$9.14M6.87%
2014-03-31$8.55M0.73%
2013-12-31$8.49M28.74%
2013-09-30$6.59M-9.57%
2013-06-30$7.29M11.21%
2013-03-31$6.56M-

Ardelyx generated $110.33M in revenue during Q3 2025, up 12.97% compared to the previous quarter, and up 150.68% compared to the same period a year ago.

Ardelyx Revenue Breakdown

Ardelyx Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23Dec 22Dec 21Dec 20
License$78.00K$35.81M$35.03M$706.00K-
Product, IBSRELA$158.29M$80.06M---
Product$319.20M$82.53M$15.60M--
Collaborative Development---$4.18M$5.36M
Product And Service Other----$1.50M

Ardelyx's latest annual revenue breakdown by segment (product or service), as of Dec 24: Product (66.84%), Product, IBSRELA (33.14%), and License (0.02%).

Quarterly Revenue by Product

Product/ServiceSep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20
Product, IBSRELA$78.16M$65.05M$53.84M$40.64M$35.45M$28.36M$8.70M-------------
License$25.00K$20.00K$5.02M$22.00K$20.00K$19.00K$17.00K$3.78M$32.01M$800.00K----------
Product$105.52M$90.08M$67.81M$111.00M$92.09M$72.59M$43.51M$30.58M$22.29M$18.31M$11.36M$8.70M$4.88M$1.56M$450.00K-----
Collaborative Development---------------$527.00K$886.00K$1.31M$1.45M$1.71M

Ardelyx's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: Product (57.44%), Product, IBSRELA (42.55%), and License (0.01%).

Ardelyx Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 24Dec 23Dec 22Dec 21Dec 20
North America$14.34M$59.00K$806.00K--
Asia Pacific$78.00K$41.12M$36.53M$10.08M$6.76M
UNITED STATES$319.20M$83.28M$15.60M--
CANADA--$31.00K$13.00K-

Ardelyx's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (95.68%), North America (4.30%), and Asia Pacific (0.02%).

Ardelyx Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
BCRXBioCryst Pharmaceuticals$450.71M$159.40M
ARDXArdelyx$333.62M$110.33M
MAZEMaze Therapeutics$167.50M-
WVEWave Life Sciences$108.30M$7.61M
STOKStoke Therapeutics$36.55M$10.63M
UPBUpstream Bio$2.37M$683.00K
NTLAIntellia Therapeutics-$13.78M
ZYMEZymeworks-$48.73M
PHVSPharvaris--
SYRESpyre Therapeutics--
TRVITrevi Therapeutics--

ARDX Revenue FAQ

What is Ardelyx’s yearly revenue?

Ardelyx's yearly revenue for 2024 was $333.62M, representing an increase of 168.06% compared to 2023. The company's yearly revenue for 2023 was $124.46M, representing an increase of 138.61% compared to 2022. ARDX's yearly revenue for 2022 was $52.16M, representing an increase of 416.57% compared to 2021.

What is Ardelyx’s quarterly revenue?

Ardelyx's quarterly revenue for Q3 2025 was $110.33M, a 12.97% increase from the previous quarter (Q2 2025), and a 12.30% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $97.66M, a 31.77% increase from the previous quarter (Q1 2025), and a 33.38% increase year-over-year (Q2 2024). ARDX's quarterly revenue for Q1 2025 was $74.11M, a -36.18% decrease from the previous quarter (Q4 2024), and a 61.04% increase year-over-year (Q1 2024).

What is Ardelyx’s revenue growth rate?

Ardelyx's revenue growth rate for the last 3 years (2022-2024) was 539.62%, and for the last 5 years (2020-2024) was 4306.49%.

What are Ardelyx’s revenue streams?

Ardelyx's revenue streams in c 24 are License, Product, IBSRELA, and Product. License generated $78K in revenue, accounting 0.02% of the company's total revenue, down -99.78% year-over-year. Product, IBSRELA generated $158.29M in revenue, accounting 33.14% of the company's total revenue, up 97.70% year-over-year. Product generated $319.2M in revenue, accounting 66.84% of the company's total revenue, up 286.78% year-over-year.

What is Ardelyx’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Ardelyx was Product. This segment made a revenue of $319.2M, representing 66.84% of the company's total revenue.